Managing Director, Biopharma
Christian Hodneland is a managing director for William Blair based in the firm’s Chicago office. He joined William Blair's investment banking team in 2006. Prior to William Blair, he worked for Arsenal Medical, Surface Logix, and Merrill Lynch.
SAMDI Tech, Inc.
Initial Public Offering
October 2024
Last week, William Blair acted as an underwriter on three healthcare IPOs: Upstream Bio’s (NASDAQ:UPB) $293 million IPO, CAMP4 Therapeutics’ (NASDAQ: CAMP) $75 million IPO, and Ceribell’s (NASDAQ: CBLL) $207 million IPO.
Read more
has acquired
June 2022
William Blair acted as the exclusive financial advisor to Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) in connection with its pending acquisition of Acacia Pharma Group plc (EURONEXT: ACPH) by way of a scheme of arrangement for €94.7 million ($104 million) in cash and Eagle Pharmaceuticals stock.
Read more
a portfolio company of AGIC Capital
has been acquired by
February 2022
William Blair in conjunction with its Asian affiliate, BDA Partners acted as exclusive financial advisors to The Ritedose Corporation, an AGIC Capital portfolio company, in connection with its pending sale to Novo Holdings.
Read more
Follow-on Offering
December 2021
has sold its consumer health assets to
July 2021
William Blair acted as the exclusive financial advisor to Akorn, Inc. in connection with the pending sale of its Consumer Health business to Prestige Consumer Healthcare.
Read more
an affiliate of Nationwide Children's Hospital
has received an investment from
a subsidiary of Danaher
March 2021
has been acquired by
October 2020
Animal Health Division
has been acquired by
July 2019
William Blair acted as the exclusive financial advisor to Perrigo Company plc (NYSE:PRGO), in connection with the pending sale of its animal health division to PetIQ, Inc. (NASDAQ:PETQ) for $185 million.
Read more
has been acquired by
May 2019
has been acquired by
April 2019
has been acquired by
July 2014
has been acquired by
April 2012
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William Blair
The rapid and cost-effective development of innovative therapeutics and treatments is critical not just to public health, but to the functioning of society and economic activity. Leading drug developers, as well as their partners across the research, development, and manufacturing value chain, count on William Blair’s deep expertise in biopharma’s capital-raising and deal-making landscape.
More about our biopharma expertise
William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*
Year William Blair was founded
Employees worldwide
Client assets
Independent and employee-owned
Offices worldwide
Companies under coverage
As of December 31, 2024
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.
This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.
Copyright © 2025 William Blair & Company, L.L.C. | Privacy Terms
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures